General

There’s a particular genre of drug question that keeps resurfacing: not the obvious “what dose should I take?” but the […]

There’s a pattern to mass adoption in pharma. First comes clinical data, then prescriber uptake, then—inevitably—the public internet asking the

Spend enough time in the DrugChatter logs and a pattern emerges. It’s not pharmacology. It’s not even really medicine. It’s

In theory, digital health queries should track clinical reality: drug–drug interactions, dosing guidance, adverse effects, and regulatory questions. In practice,

While DrugChatter is a specialized platform for medication discussions, many of the most surprising side effects surfaced by its users

Summary:Patient interest clusters heavily around drug–drug interactions, food effects, and therapeutic alternatives. Statins (especially Lipitor), biologics like Cosentyx, and common

Scroll through enough patient forums and a pattern emerges: people aren’t just asking about side effects—they’re experimenting in real time.

There used to be a reliable playbook. You identified the twenty physicians who shaped prescribing behavior in a given therapeutic

The correlation had been hiding in plain sight for two years before anyone in pharmaceutical commercial analytics thought to look

Somewhere right now, a patient is asking an AI chatbot whether their oncology drug causes liver failure. The chatbot is

Every time ChatGPT answers a drug question, it may be doing something no FDA-approved ad campaign ever could — and

The standard pharmacovigilance process has a timing problem Adverse events travel faster than case reports. A patient posts about a